Research news highlights a science breakthrough in CRISPR gene editing, and stem cell transplants provide curative potential for monogenic inflammatory bowel disease.
Scientists, staff, and students from CHOP and the University of Pennsylvania community celebrated the next generation of pediatric researchers and the continuation of collaborative scientific discovery at the Poster Day and Scientific Symposium.
Melding together genomics technology, disease patterns, immunology, and microbiology, physician-scientists at The Children’s Hospital of Philadelphia are finding new and individualized therapies for patients with very early onset inflammatory bowel disease.
A study published in the Journal of Clinical Endicronology & Metabolism shows a drug approved to treat Crohn’s disease and ulcerative colitis leads to “rapid improvements” in bone density and structure.